X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

期刊標題檢索 BBA-REV CANCER 最新評論: How long will it take for you to reply? (2024-05-22)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER]您好,您是該頁面的第 32865 位訪客。

期刊簡介
期刊名稱BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
LetPub Score
7.9
50 ratings
Rate

Reputation
8.8

Influence
6.9

Speed
8.8

期刊簡稱BBA-REV CANCER
ISSN0304-419X
E-ISSN1879-2561
h-index129
CiteScore
CiteScoreSJRSNIPCiteScore Rank
17.202.8381.954
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q116 / 347
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Oncology
Q127 / 404
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q120 / 230

自引率 (2023-2024)1.00%自引率趨勢
掲載範囲
BBA Reviews on Cancer covers the whole field of the biology and biochemistry of cancer, emphasizing oncogenes and tumor suppressor genes, growth-related cell cycle control signalling, carcinogenesis mechanisms, cell transformation, immunologic control mechanisms, genetics of human (mammalian) cancer, control of cell proliferation, genetic and molecular control of organismic development, rational anti-tumor drug design. In short, the journal presents critical invited reviews on new developments in cancer investigation at the molecular level.
官方網站http://www.journals.elsevier.com/bba-reviews-on-cancer/
在線稿件提交http://ees.elsevier.com/bbacan/default.asp?acw=ff33
開放訪問No
出版商Elsevier
主題領域医学
出版國/地區NETHERLANDS
發行頻率四半期刊行
創刊年0
每年文章數161每年文章數趨勢
黃金OA百分比22.22%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ120/313
BIOPHYSICSSCIEQ15/77
ONCOLOGYSCIEQ129/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0304-419X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
來自Elsevier的數據: Average 4.9 Week(s)
競爭力 *來自作者的數據: About 50%
在線文章發布時間來自Elsevier的數據: Average 5.8 Week(s)
參考鏈接
相關期刊 【BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1278776
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS570957
    JOURNAL OF BIOLOGICAL CHEMISTRY395991
    NUCLEIC ACIDS RESEARCH338136
    CELL298253
    FASEB JOURNAL267141
    International Journal of Biological Sciences236839
    PLANT SCIENCE228209
    Molecular Cancer212743
    ONCOGENE200846
  •  

    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER] 的評論撰寫評論
作者: 珉林辛亥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-22 15:56:30 評論於
How long will it take for you to reply?
(0) 讚! | 珉林辛亥

作者: 葵花雨珍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-17 14:06:49 評論於
How about a few days for a change?
(0) 讚! | 葵花雨珍

作者: dcshyc


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-09 08:01:47 評論於
Is there any result for me as well? It's been over half a month, has the status not changed after the external review?
(0) 讚! | dcshyc

作者: dcshyc


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-09 07:59:44 評論於
It has been more than half a month since I submitted the manuscript to the editor
(0) 讚! | dcshyc

作者: 北风文彦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-14 19:08:22 評論於
Hello, may I ask if there have been any developments lately? I have been with editor for 15 days
(0) 讚! | 北风文彦

作者: 润发大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-10 18:14:51 評論於
Review Speed: 12.0 | Acceptance Rate: 50.0
Experience Sharing: After submitting for a year, I finally got accepted without any publication fee. They immediately edited the paper and it was online the same day. A great New Year's gift
(0) 讚! | 润发大叔

作者: 中原向雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-29 23:51:25 評論於
Focused research direction: Tumor experience sharing: with editor It's been 15 days, is it so slow?
(0) 讚! | 中原向雪

作者: 北风笑萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-28 12:34:24 評論於
Review Speed: 2.0 | Submission Acceptance Rate: 50.0
Experience Sharing: 1
(0) 讚! | 北风笑萍

作者: 龟甲林楠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-13 22:26:35 評論於
 (0) 讚! | 龟甲林楠  

作者: 龟甲林楠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-13 19:21:33 評論於
There is no text to translate
(0) 讚! | 龟甲林楠

作者: 龟甲林楠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-13 09:32:28 評論於
I don't know
(0) 讚! | 龟甲林楠

作者: 羽彤mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-08 09:46:31 評論於
How to contact the editor-in-chief?
(0) 讚! | 羽彤mm

作者: 子薇姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-19 13:16:26 評論於
Review speed: 2.0 | Submission acceptance rate: 25.0 Emphasized research directions: Tumor; Tumor treatment; Tumor markers Experience sharing: Sent an abstract to the editor-in-chief first, and started writing the paper after his approval. Got feedback in less than 2 months, the reviewers were very serious and provided a lot of comments. After major revisions, the paper was submitted again, and after minor revisions about a month later, it was accepted. The entire process took less than three months. No charges
(0) 讚! | 子薇姑娘

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:05:30 評論於
According to the format requirements of the corresponding journal, write accordingly. If there is no fixed format, you can choose a suitable format depending on the type of article. Regardless of the format, structuring the abstract makes the data information clearer and more understandable
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:35:50 評論於
Different types: Descriptive, Informational, and Structured. Descriptive abstracts are typically used in social sciences and humanities, providing general information about the research without specific details on methods and conclusions. Informational abstracts are commonly found in scientific papers, presenting details about the research background, objectives, methods, results, and conclusions. Structured abstracts are information-focused, composed of a series of headings (e.g. research objectives, methods, results, conclusions), mainly used in medical papers and clinical trial reports
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 08:58:04 評論於
What kind of format would be preferred for writing an abstract?
(0) 讚! | 北国博达

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 19:20:59 評論於
How to choose between structured abstracts and full paragraph abstracts?
(0) 讚! | 平原文波

作者: 茂勋小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-12 18:21:43 評論於
Should the images and tables be placed in a separate folder when submitting a manuscript, or should they be placed next to the text?
(0) 讚! | 茂勋小娘子

作者: 乌龙姝丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-09 21:58:48 評論於
Is this magazine directly commissioned?
(0) 讚! | 乌龙姝丽

作者: 拈花振杰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-12-29 13:58:39 評論於
Can META analysis be submitted?
(0) 讚! | 拈花振杰

作者: Kinfe


領域: 医学
審稿時間: 4.0 month(s)
結果: 拒稿


撰寫評論

2018-11-15 11:50:23 評論於
It’s not easy to give a major overhaul, after the modification is rejected, really helpless
(0) 讚! | Kinfe

作者: Mabel Hewlett


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-15 10:34:32 評論於
Review Speed: 3.0 | Submission Success Rate: 75.0
Experience Sharing: It's really frustrating when you finally get a major revision, but still get rejected after making all the changes. It's really disappointing
(0) 讚! | Mabel Hewlett

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 17:56:37 評論於
"Up is just a word, happily welcome the rise. Seeing this momentum, breaking through 10 points in the future is in sight! I am in Anhui, can I publish an article, satisfied"
(0) 讚! | 凌霄高洁

作者: 凌霄淑懿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-03-06 17:18:11 評論於
Review Speed: 1.0 | Acceptance Rate: 50.0
Experience Sharing: Generally commissioned. The speed is quite fast, with the initial review taking about 3 weeks. The reviewers are quite rigorous and provide many comments. However, once revisions are made, acceptance is quick without any further modifications. The revision period is 3 months. Online within a week
(0) 讚! | 凌霄淑懿

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*